home / stock / cool:cc / cool:cc news

COOL:CC News and Press, Core One Labs Inc. From 07/11/23

Stock Information
Company Name: Core One Labs Inc.
Stock Symbol: COOL:CC
Market: CNQC
Menu
COOL:CC COOL:CC Quote COOL:CC Short COOL:CC News COOL:CC Articles COOL:CC Message Board
Get COOL:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
COOL:CC - Core One's Vocan Biotechnologies Incorporates New Bioreactor Equipment into Production Process Significantly Increasing Throughput of Proprietary Biosynthetic Psilocybin

VANCOUVER, BC / ACCESSWIRE / July 11, 2023 / Core One Labs Inc. (CSE: COOL ), (OTCQB: CLABF ), (Frankfurt: LD6 , WKN: A3CSSU ) (the " Company ") is pleased to announce that its wholly-owned subsidiary Vocan Biotechnologies Inc. (" Vocan ") has incorporated a state-of-the-art, high density, fer...
COOL:CC - Core One's Vocan Files International Patent for its Breakthrough Proprietary Biosynthetic Psilocybin Production Method

VANCOUVER, BC / ACCESSWIRE / July 7, 2023 / Core One Labs Inc. (CSE: COOL ), (OTCQB: CLABF ), (Frankfurt: LD6 ), (WKN: A3CSSU) (the " Company " or " Core One ") is pleased to announce that its wholly owned subsidiary, Vocan Biotechnologies Inc. (" Vocan "), has completed final steps of its r...

COOL:CC - Core One in Talks with Multiple Companies to Supply Psilocybin

VANCOUVER, BC / ACCESSWIRE / May 5, 2023 / Core One Labs Inc. (CSE: COOL )(OTCQB: CLABF )(Frankfurt: LD6) , (WKN:A3CSSU) (the " Company " or " Core One ") is pleased to announce that it is in discussions with several pharmaceutical laboratories and research organizations to supply them with ac...

COOL:CC - Core One Labs' GMP Drug Takes Further Steps Toward Commercialization: Initiating Development of Psychedelic Prodrugs with Long-established Compounding Pharmacy

VANCOUVER, BC / ACCESSWIRE / May 1, 2023 / Core One Labs Inc. (CSE: COOL )(OTCQB: CLABF )(Frankfurt: LD6 )(WKN:A3CSSU) (the " Company " or " Core One ") is pleased to announce that its wholly-owned subsidiaries, GMP Drug Inc., and Awakened Biosciences Inc. (" Awakened ") will commence the de...
COOL:CC - Core One's Awakened Completes Successful Synthetic Production of Psilocin in its GMP Certified Manufacturing Facility

VANCOUVER, BC / ACCESSWIRE / April 21, 2023 / Core One Labs Inc. (CSE: COOL )(OTCQB: CLABF )(Frankfurt: LD6 , WKN:A3CSSU) (the " Company " or " Core One ") is pleased to announce that its wholly-owned subsidiary, Awakened Biosciences Inc. (the " Subsidiary " or " Awakened ") has successfully c...

COOL:CC - Core One Labs' Akome Signs Contract with University of Barcelona: Initiating Animal Model Studies on Psychedelics Drug Development to Combat a Variety of Neurological Diseases

VANCOUVER, BC / ACCESSWIRE / January 24, 2023 / Core One Labs Inc. (CSE: COOL )(OTCQB: CLABF )(Frankfurt: LD6)( WKN: A3CSSU) (the " Company " or " Core One "), in follow-up to its press release dated September 16, 2022, is pleased to announce that its wholly owned subsidiary Akome Biotech Ltd. (...

COOL:CC - Core One Labs' Acquires GMP Drug Inc.: Positioning Itself as a Full Cycle Psychedelics Supply Chain Solution for Clinicians, Researchers and Other Drug Developers

VANCOUVER, BC / ACCESSWIRE / January 13, 2023 / Core One Labs Inc. (CSE: COOL )(OTCQB: CLABF )(Frankfurt: LD6 )(WKN: A3CSSU) (the " Company " or " Core One "), is pleased to announce that it has acquired (the " Acquisition ") GMP Drug Inc. (" GMP Drug "), an arms-length privately held company th...
COOL:CC - Core One Labs' Prepares for Commercial Production of API-Grade Psilocybin; Plans Initial Production Run at GMP Facility in January

VANCOUVER, BC / ACCESSWIRE / November 18, 2022 / Core One Labs Inc. (CSE: COOL ), (OTCQB: CLABF ), (Frankfurt: LD6 , WKN:A3CSSU) (the " Company " or " Core One ") is pleased to announce the initial production run of its psilocybin active pharmaceutical ingredient (API) product at a good ma...

COOL:CC - Core One Labs Takes Next Steps to Prepare for Potential Takeover Opportunities

VANCOUVER, BC / ACCESSWIRE / October 21, 2022 / Core One Labs Inc. (CSE: COOL ), (OTCQB: CLABF ), (Frankfurt: LD6 , WKN:A3CSSU) (the " Company " or " Core One ") is pleased to announce, as a follow up to the Company's press release dated March 20, 2022, wherein the Company announced that it ...

COOL:CC - European University to Fund Core One Labs' Akome Advanced Neurogenesis Stimulation Studies

VANCOUVER, BC / ACCESSWIRE / October 14, 2022 / Core One Labs Inc. (CSE:COOL)(OTCQB:CLABF)(Frankfurt:LD6)(WKN:A3CSSU) (the " Company " or " Core One "), further to its press release dated August 18, 2022, is excited to announce its wholly owned subsidiary, Akome Biotech Ltd. (" Akome "),...
Previous 10 Next 10